First‐in‐Man Study of the Low‐Dose Paclitaxel Using the COBRA‐P Drug‐Eluting Coronary Stent System With a Novel Biodegradable Coating in De Novo Coronary Lesions

Publisher: John Wiley & Sons Inc

E-ISSN: 1522-726x|84|7|1101-1109

ISSN: 1522-1946

Source: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol.84, Iss.7, 2014-12, pp. : 1101-1109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content